Innovating Upstream AAV Manufacturing For The Next Wave Of Gene Therapies

Adeno-associated viruses continue to anchor the gene therapy landscape, yet transient production often comes with unpredictable yields and complex optimization demands. This webinar introduces a streamlined approach for improving upstream AAV manufacturing using the AAViator™ Production Platform—a transfection solution designed for HEK293-based systems. The session walks through data comparing performance against polymer-only and lipid-only reagents, with results generated across multiple serotypes, diverse transgenes, and commonly used HEK293 lineages. You’ll also see how the platform performs from small-scale work through bench-scale bioreactors, and what consistent gains can mean for batch economics and dose costs.

If you’re looking to simplify development, enhance productivity, or evaluate scalable options for AAV manufacturing, gain actionable guidance grounded in real-world process data.